Atlas Trials

A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1

Clinical trial NCT05184829 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05184829
Sponsor
Shanghai Zhongshan Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
ProgressionPostoperative Recovery
Start date
2022-01-01
Primary completion
2028-12-31
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.